Related Experiment Video
Updated: Aug 8, 2026

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10
Sirirat Klongpanichapak1, Piyarat Govitrapong, Sushil K Sharma
1Department of Pharmacology, Physiology and Therapeutics, School of Medicine & Health Sciences, University of North Dakota, 501 North Columbia Road, Grand Forks, ND, 58203, USA.
Abstract:
The neurotoxic effects of cocaine and methamphetamine (METH) were studied in mice brain with a primary objective to determine the neuroprotective potential of coenzyme Q10 (CoQ10) in drug addiction. Repeated treatment of cocaine or METH induced significant reduction in the striatal dopamine and CoQ10 in mice. Cocaine or METH-treated mice exhibited increased thiobarbituric acid reactive substances (TBARs) in the striatum and cerebral cortex without any significant change in the cerebellum. Complex I immunoreactivity was inhibited in both cocaine and METH-treated mice, whereas tyrosine hydroxylase (TH) immunoreactivity was decreased in METH-treated mice and increased in cocaine-treated mice. Neither cocaine nor METH could induce significant change in alpha-synuclein expression at the doses and duration we have used in the present study. CoQ10 treatment attenuated cocaine and METH-induced inhibition in the striatal 18F-DOPA uptake as determined by high-resolution microPET neuroimaging. Hence exogenous administration of CoQ10 may provide neuroprotection in drug addiction.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Risk factors
Drug toxicity: Drug–Drug Interaction
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
